Dighiero G, Bodega E, Mayzner R, Binet J L
Blood. 1980 Jan;55(1):93-100.
A new quantitative immunoperoxidase method is presented for determining absolute amounts of peroxidase and, consequently, surface antigen densities of individual cells in B lymphocytes from normal individuals, from subjects with CLL and prolymphocytic leukemia, and during ontogeny of B lympocytes in the mouse. The following results were observed: (1) The density of B antigenic sites were lower on CLL than on normal B lymphocytes. (2) The B antigens density of leukemic lymphocytes varied less from cell to cell, forming a homogeneous peak on histograms. (3) In a very rare case of CLL, the antigen density was measured at the time of initial diagnosis (22,500 sites or 647 U) and during the development of a blastic crisis (135,000 sites or 2576 U). The cell by cell distribution changed from a homogeneous peak with a low number of antigenic sites per cell to a heterogeneous peak with a high number of antigenic sites per cell. (4) In prolymphocytic leukemia, the density of B antigenic sites was greater than on normal B lymphocytes and much more heterogeneous than on CLL lymphocytes. (5) During ontogeny of B lymphocytes in the mouse, maturation is associated with the appearance of a population of cells of intermediate to high Smig density. The finding of a decrease in, and altered distribution of, surface markers in CLL is compared with these ontologic findings in the mouse, and the concept that a monoclonal B lymphocyte in CLL may be arrested at a particular stage in its differentiation is discussed.
本文介绍了一种新的定量免疫过氧化物酶方法,用于测定过氧化物酶的绝对含量,从而测定正常个体、慢性淋巴细胞白血病(CLL)和幼淋巴细胞白血病患者的B淋巴细胞以及小鼠B淋巴细胞个体发育过程中单个细胞的表面抗原密度。观察到以下结果:(1)CLL患者B抗原位点的密度低于正常B淋巴细胞。(2)白血病淋巴细胞的B抗原密度在细胞间变化较小,在直方图上形成一个均匀的峰值。(3)在一例非常罕见的CLL病例中,在初始诊断时(22,500个位点或647 U)和原始细胞危象发展过程中(135,000个位点或2576 U)测量了抗原密度。逐个细胞的分布从每个细胞抗原位点数量少的均匀峰值变为每个细胞抗原位点数量多的异质峰值。(4)在幼淋巴细胞白血病中,B抗原位点的密度高于正常B淋巴细胞,且比CLL淋巴细胞的异质性大得多。(5)在小鼠B淋巴细胞个体发育过程中,成熟与中等至高Smig密度的细胞群体的出现有关。将CLL中表面标志物减少和分布改变的发现与小鼠的这些个体发育学发现进行了比较,并讨论了CLL中的单克隆B淋巴细胞可能在其分化的特定阶段停滞的概念。